Anti-CD62L antibody [DREG56] {PE/TR} (STJA0004116)

SKU:
STJA0004116

Current Stock:
Host: Mouse
Applications: FC
Reactivity: Human
Note: FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-L-Selectin is suitable for use in Flow Cytometry research applications.
Clonality: Monoclonal
Clone ID: DREG56
Conjugation: PE/TR
Isotype: IgG1k
Formulation: PBS with 0.05% Proclin300, 1% BSA
Storage Instruction: Recommend storing between 2-8°C and protecting from prolonged exposure to light. Do not freeze this product.
Gene Symbol: SELL
Gene ID: 6402
Uniprot ID: LYAM1_HUMAN
Tissue Specificity Expressed in B-cell lines and T-lymphocytes.
Post Translational Modifications N-glycosylated.
Function Calcium-dependent lectin that mediates cell adhesion by binding to glycoproteins on neighboring cells. Mediates the adherence of lymphocytes to endothelial cells of high endothelial venules in peripheral lymph nodes. Promotes initial tethering and rolling of leukocytes in endothelia.
Protein Name L-Selectin
Cd62 Antigen-Like Family Member L
Leukocyte Adhesion Molecule 1
Lam-1
Leukocyte Surface Antigen Leu-8
Leukocyte-Endothelial Cell Adhesion Molecule 1
Lecam1
Lymph Node Homing Receptor
Tq1
Gp90-Mel
Cd Antigen Cd62l
Database Links Reactome: R-HSA-198933
Reactome: R-HSA-202733
Reactome: R-HSA-6798695
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Alternative Antibody Names Anti-L-Selectin antibody
Anti-Cd62 Antigen-Like Family Member L antibody
Anti-Leukocyte Adhesion Molecule 1 antibody
Anti-Lam-1 antibody
Anti-Leukocyte Surface Antigen Leu-8 antibody
Anti-Leukocyte-Endothelial Cell Adhesion Molecule 1 antibody
Anti-Lecam1 antibody
Anti-Lymph Node Homing Receptor antibody
Anti-Tq1 antibody
Anti-Gp90-Mel antibody
Anti-Cd Antigen Cd62l antibody
Anti-SELL antibody
Anti-LNHR antibody
Anti-LYAM1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance